Girard, P M <br/><br/>
Phase II study of liposomal encapsulated daunorubicin in the treatment of AIDS-associated mucocutaneous Kaposi's sarcoma.  [electronic resource] 

 -  AIDS (London, England)  Jun 1996 
 - 753-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>0269-9370 
<br/><br/><label>Standard No.: </label>10.1097/00002030-199606001-00009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acquired Immunodeficiency Syndrome--complications<br/>Adult<br/>Antibiotics, Antineoplastic--administration & dosage<br/>Daunorubicin--administration & dosage<br/>Disease Progression<br/>Drug Carriers<br/>Humans<br/>Liposomes<br/>Male<br/>Middle Aged<br/>Reaction Time<br/>Remission Induction<br/>Sarcoma, Kaposi--drug therapy